Outcomes and hospitalization patterns of patients with acute myelogenous leukemia treated with frontline CPX-351 or HMA/venetoclax.
Chojecki AL, Arnall J, Boselli D, Patel R, Chiad Z, DiSogra KY, Karabinos A, Chen T, Cruz A, Verbyla A, Ai J, Knight TG, Ragon BK, Shah NA, Sanikommu SR, Symanowski J, Avalos BR, Copelan EA, Grunwald MR.
Chojecki AL, et al.
Leuk Res. 2022 Aug;119:106904. doi: 10.1016/j.leukres.2022.106904. Epub 2022 Jun 21.
Leuk Res. 2022.
PMID: 35753088
No abstract available.